Transdermal Drug Delivery Market : Industry Demands, Top Key Players, Industry Analysis & Forecast By 2016 - 2026

Transdermal drug delivery is a mode of drug administration in which drug is administered through patient’s skin. The drugs or medicine that needs to be administered to a patient are usually applied in the form of a plaster, patch, or ointment in this administration route such that the drugs are gradually absorbed into the systemic circulation. Transdermal drug delivery systems (TDDS) are generally comprised of five key components: the drug, polymer matrix, permeation enhancers, adhesives, and backing layers.

View Report: https://www.transparencymarketresearch.com/transdermal-drug-delivery-market.html

Transdermal drug delivery system has several advantages such as:

The delivery of drug is non-invasive which is very less painful to the patient as compared to other forms of drug administration
Avoids first-pass metabolism thus increasing the bio-availability of drug
Transdermal drug delivery have fewer side effects than oral medications or supplements
Administration of complete dose of the drug is possible through TDDS
Provides controlled plasma levels of very potent drugs
Termination of therapy is easy at any point of time
Reduction in healthcare costs due to higher compliance & more effective treatment

Factors that directly affect the quality, permeation and efficacy of transdermal drug delivery include morphology and physiology of skin and the combination of skin, penetrant and delivery system.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=158

The transdermal drug delivery market is driven by the introduction of easy-to-use and effective transdermal drug delivery systems based on cutting-edge technology. The transdermal drug delivery market is increasing due to its rising demand as it is more convenient than conventional systems for administrating drugs. For example, patients that are fanatical to oral drug dosages or those patients in unconscious state can be administered drugs through the transdermal route.

Transdermal patches provides improved control over toxicity levels as these patches can be easily peeled off if the drug is scrutinized to render higher toxic effects. Drug permeation can be monitored and estimated more effectively through this method, which makes it convenient to maintain a constant level of drug serum. In view of these factors, the adoption rate of products in the global transdermal drug delivery market is high. By application, the global transdermal drug delivery market can be classified as hormone replacement therapy, pain management, contraception, neurological disorders, and smoking cessation. Transdermal drug delivery system is one of the fastest growing segments of the total drug delivery sector as it is the most convenient drug delivery system.

Geographically, the global transdermal drug delivery market is segmented into North America, Europe, Asia Pacific and Rest of the World. Nicotine patch is highly sold in the United States. This patch releases nicotine in controlled manner to help with the cessation of tobacco smoking. In Europe, the first commercially available vapour patch was approved in 2007 to reduce smoking habits. Transdermal patches are gaining share in the global transdermal drug delivery market penetration because primary care physicians and patients equally put more emphasis on easy to use drug delivery methods.

Request TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=158

Some of the key global participants present in the transdermal drug delivery market include 3M Pharmaceuticals Inc., Actelion Pharmaceuticals Ltd, Bayer Crop Science Ltd., BioGel Technology Inc., Upsher-Smith Laboratories, Inc., Johnson & Johnson Limited, Mylan Pharmaceuticals Inc., GlaxoSmithKline plc, Novartis AG, Janssen Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., Boehringer Ingelheim GmbH and Actavis Inc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.